Published in Neuropsychopharmacology on June 20, 2012
Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry (2014) 1.14
Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice. Neuropsychopharmacology (2013) 0.90
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. J Neuroimmune Pharmacol (2015) 0.80
Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome. Schizophr Bull (2015) 0.79
Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans. Neuropsychopharmacology (2015) 0.78
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome. J Clin Sleep Med (2014) 0.76
Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis. Psychopharmacology (Berl) (2014) 0.76
Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users. Neuropsychopharmacology (2014) 0.76
Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis. J Psychopharmacol (2014) 0.76
An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity. Neuropharmacology (2015) 0.75
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol (2017) 0.75
EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods (2004) 34.47
A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol (1983) 12.44
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Neuronal synchrony: a versatile code for the definition of relations? Neuron (1999) 7.74
The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology (1987) 6.64
Role of endogenous cannabinoids in synaptic signaling. Physiol Rev (2003) 5.70
Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol (1988) 5.54
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther (1997) 5.20
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci (1999) 4.65
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience (1998) 4.39
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry (1999) 3.74
A 40-Hz auditory potential recorded from the human scalp. Proc Natl Acad Sci U S A (1981) 3.72
Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci (2006) 3.09
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci (2000) 2.69
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Synchronization of neural activity across cortical areas correlates with conscious perception. J Neurosci (2007) 2.49
Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr Bull (2008) 2.44
Neural synchrony in cortical networks: history, concept and current status. Front Integr Neurosci (2009) 2.42
Pharmacology of cannabinoid receptor ligands. Curr Med Chem (1999) 2.34
Human auditory steady-state responses. Int J Audiol (2003) 2.32
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci (2005) 2.32
Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biol Psychiatry (2006) 2.25
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature (2004) 1.92
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. Eur J Neurosci (2010) 1.77
Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biol Psychiatry (2008) 1.75
The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci (2007) 1.68
A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry (2010) 1.62
Neuronal fast oscillations as a target site for psychoactive drugs. Pharmacol Ther (2000) 1.61
Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J Comp Neurol (2000) 1.58
The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc (1971) 1.44
Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci (2006) 1.40
Tolerance and disposition of tetrahydrocannabinol in man. J Pharmacol Exp Ther (1980) 1.40
Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol (2007) 1.30
Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry (2008) 1.30
Neuromagnetic steady-state responses to auditory stimuli. J Acoust Soc Am (1989) 1.27
Tonotopic organization of the sources of human auditory steady-state responses. Hear Res (1996) 1.26
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience (2000) 1.25
Evidence for cortical origin of the 40 Hz auditory evoked response in man. Electroencephalogr Clin Neurophysiol (1987) 1.25
Steady state and induced auditory gamma deficits in schizophrenia. Neuroimage (2009) 1.24
Activation of human cerebral and cerebellar cortex by auditory stimulation at 40 Hz. J Neurosci (2002) 1.23
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol (2005) 1.17
Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport (2004) 1.12
Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience (2010) 1.10
Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol (2008) 1.10
Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berl) (2004) 1.09
Wiring and firing neuronal networks: endocannabinoids take center stage. Curr Opin Neurobiol (2008) 1.08
Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res (2011) 1.02
Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology (2007) 1.01
Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology (2010) 0.99
Regulation of IPSP theta rhythm by muscarinic receptors and endocannabinoids in hippocampus. J Neurophysiol (2005) 0.96
GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia. Int J Neuropsychopharmacol (2009) 0.95
Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy. Am J Psychiatry (2006) 0.95
Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders. Bipolar Disord (2010) 0.93
The effect of cannabis use and gender on the visual steady state evoked potential. Clin Neurophysiol (2005) 0.93
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms. Neuropsychopharmacology (2010) 0.89
[Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia]. Rev Bras Psiquiatr (2010) 0.87
Cannabinoid modulations of resting state EEG θ power and working memory are correlated in humans. J Cogn Neurosci (2010) 0.87
Assessment of forebrain-dependent trace eyeblink conditioning in chronic cannabis users. Neurosci Lett (2008) 0.84
Modulation of steady-state auditory evoked potentials by cerebellar rTMS. Exp Brain Res (2006) 0.84
Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations. Behav Neurosci (2009) 0.82
Gamma oscillation in schizophrenia. Psychiatry Investig (2011) 0.81
Potential fMRI correlates of 40-Hz phase locking in primary auditory cortex, thalamus and midbrain. Neuroimage (2010) 0.81
Modulation of network oscillatory activity and GABAergic synaptic transmission by CB1 cannabinoid receptors in the rat medial entorhinal cortex. Neural Plast (2008) 0.80
Neuromagnetic responses of human auditory cortex to interruptions in a steady rhythm. Neurosci Lett (1989) 0.76
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. J Clin Psychiatry (2012) 1.67
A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry (2010) 1.62
P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res (2008) 1.52
Neural circuitry and plasticity mechanisms underlying delay eyeblink conditioning. Learn Mem (2011) 1.41
EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder. Am J Psychiatry (2003) 1.35
Steady state responses: electrophysiological assessment of sensory function in schizophrenia. Schizophr Bull (2009) 1.33
Haloperidol impairs learning and error-related negativity in humans. J Cogn Neurosci (2004) 1.29
Eye-blink conditioning deficits indicate temporal processing abnormalities in schizophrenia. Schizophr Res (2009) 1.22
Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry (2011) 1.20
Event-related potential correlates of task switching and switch costs. Psychophysiology (2005) 1.19
Temporal processing dysfunction in schizophrenia. Brain Cogn (2008) 1.19
Steady state visual evoked potential abnormalities in schizophrenia. Clin Neurophysiol (2005) 1.17
Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport (2004) 1.12
Synchronization dynamics and evidence for a repertoire of network states in resting EEG. Front Comput Neurosci (2012) 1.12
Personality traits in schizophrenia and related personality disorders. Psychiatry Res (2005) 1.11
Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophr Res (2005) 1.11
Eye gaze and individual differences consistent with learned attention in associative blocking and highlighting. J Exp Psychol Learn Mem Cogn (2005) 1.09
Timing dysfunctions in schizophrenia span from millisecond to several-second durations. Brain Cogn (2009) 1.07
Psychometrically matched visual-processing tasks in schizophrenia spectrum disorders. J Abnorm Psychol (2003) 1.05
Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information? Schizophr Res (2009) 1.04
Temporal discounting of rewards in patients with bipolar disorder and schizophrenia. J Abnorm Psychol (2011) 1.04
Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders. Schizophr Bull (2010) 1.04
The effect of selective attention on the gamma-band auditory steady-state response. Neurosci Lett (2007) 1.03
The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology (2013) 1.02
Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res (2011) 1.02
Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography. Biol Psychiatry (2009) 1.02
Personality differences in schizophrenia are related to performance on neuropsychological tasks. J Nerv Ment Dis (2005) 1.02
A multimethod investigation of the behavioral activation system in bipolar disorder. J Abnorm Psychol (2008) 1.02
Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology (2007) 1.01
The startle reflex in schizophrenia: habituation and personality correlates. Schizophr Res (2003) 0.97
A new statistical method for testing hypotheses of neuropsychological/MRI relationships in schizophrenia: partial least squares analysis. Schizophr Res (2002) 0.97
Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task. Brain Cogn (2009) 0.97
Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. Eur Neuropsychopharmacol (2012) 0.97
Event related brain potential evidence for preserved attentional set switching in schizophrenia. Schizophr Res (2007) 0.95
Switch and maintenance of task set in schizophrenia. Schizophr Res (2006) 0.95
Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction. Bipolar Disord (2009) 0.95
Attention and emotional responses to sexual stimuli and their relationship to sexual desire. Arch Sex Behav (2007) 0.95
GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia. Int J Neuropsychopharmacol (2009) 0.95
Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy. Am J Psychiatry (2006) 0.95
A longitudinal twin study of effects of adolescent alcohol abuse on the neurophysiology of attention and orienting. Alcohol Clin Exp Res (2011) 0.94
Cerebellum volume and eyeblink conditioning in schizophrenia. Psychiatry Res (2008) 0.94
Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders. Bipolar Disord (2010) 0.93
The effect of cannabis use and gender on the visual steady state evoked potential. Clin Neurophysiol (2005) 0.93
Disruption of neural systems of visual attention in schizophrenia. Arch Gen Psychiatry (2002) 0.93
Decision making in bipolar disorder: a cognitive modeling approach. Psychiatry Res (2008) 0.92
Subjective perceptual distortions and visual dysfunction in children with autism. J Autism Dev Disord (2006) 0.90
Increased temporal variability of auditory event-related potentials in schizophrenia and Schizotypal Personality Disorder. Schizophr Res (2010) 0.89
Motor deficits in schizophrenia quantified by nonlinear analysis of postural sway. PLoS One (2012) 0.89
Aberrant auditory processing in schizophrenia and in subjects at ultra-high-risk for psychosis. Schizophr Bull (2011) 0.89
P50 and acoustic startle gating are not related in healthy participants. Psychophysiology (2004) 0.89
Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence. Neuropsychopharmacology (2010) 0.89
Disturbed resting state EEG synchronization in bipolar disorder: A graph-theoretic analysis. Neuroimage Clin (2013) 0.88
Perceptual anomalies in schizophrenia co-occur with selective impairments in the gamma frequency component of midlatency auditory ERPs. J Abnorm Psychol (2008) 0.88
Auditory steady state response in the schizophrenia, first-degree relatives, and schizotypal personality disorder. Schizophr Res (2012) 0.87
Secretin effects on cerebellar-dependent motor learning in schizophrenia. Am J Psychiatry (2009) 0.87
An MEG study of alpha modulation in patients with schizophrenia and in subjects at high risk of developing psychosis. Schizophr Res (2010) 0.87
Early stage vision in schizophrenia and schizotypal personality disorder. Schizophr Res (2006) 0.87
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. J Clin Psychiatry (2010) 0.87
Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. PLoS One (2011) 0.87
Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. Drug Alcohol Depend (2012) 0.87
Visual processing and neuropsychological function in schizophrenia and schizoaffective disorder. Psychiatry Res (2002) 0.86
Computer-assisted cognitive remediation for schizophrenia: a randomized single-blind pilot study. Schizophr Res (2012) 0.85
Contributions of spectral frequency analyses to the study of P50 ERP amplitude and suppression in bipolar disorder with or without a history of psychosis. Bipolar Disord (2008) 0.85
Psychometrically matched tasks evaluating differential fMRI activation during form and motion processing. Neuropsychology (2011) 0.85
The auditory steady-state response (ASSR): a translational biomarker for schizophrenia. Suppl Clin Neurophysiol (2013) 0.84